Petauri™ Announces Evolution of The Kinetix Group–Powered by Petauri™
Rapidly growing pharmaceutical services provider responds to high growth areas with 2 new adjacent business units NASHVILLE, Tenn., Oct. 30, 2024...
Pharmaceutical
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
AlzeCure Presents New Anti-Inflammatory Data with NeuroRestore ACD856 at the Alzheimer’s Conference CTAD
STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024
HAMBURG, GERMANY / ACCESSWIRE / October 30, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) will announce its financial...
Medexus Schedules Second Fiscal Quarter 2025 Conference Call
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 29, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host...
10x Genomics Reports Third Quarter 2024 Financial Results
PLEASANTON, Calif., Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance
NORTHAMPTON, MA / ACCESSWIRE / October 29, 2024 / Diversity and inclusion are not only core elements of Teva's cultural...
Synoligo Biotechnologies Unveils New Facility to Enhance Oligonucleotide Synthesis Capacity
MORRISVILLE, N.C., Oct. 29, 2024 /PRNewswire/ -- Synoligo Biotechnologies Inc., a Contract Research and Development Organization (CRDO) based in Research...
DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening
Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO...
QuantalX Introduces a Breakthrough in the Diagnosis and Classification of Parkinson’s Disease
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the...
CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool – a first-of-its-kind capability in the world of scientific technology solutions
The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio,...
Top 10 Pharma Selects TrueMed for Advanced Counterfeit Drug Investigations
HELSINKI, Oct. 29, 2024 /PRNewswire/ -- TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership...
AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery
ProPhet, Newest Startup Launched by Israel-Based Venture Studio, Aims to Reduce Time and Cost of Finding Molecules for New Drug...
Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing...
Significant Positive Results with Jaguar Health’s Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / October...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q)...
Sensio Air Wins Prestigious Red Dot Award for Design Excellence
Innovative Airborne Pathogen Monitoring Device Recognized for Outstanding Design and FunctionalitySUNNYVALE, CA / ACCESSWIRE / October 29, 2024 / Sensio...
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today...
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos...
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical...